The ROE as of September 2024 (TTM) for Miromatrix Medical Inc. (MIRO) is -119.21%

According to Miromatrix Medical Inc.’s latest financial reports and current stock price. The company's current ROE is -119.21%. This represents a change of 283.63% compared to the average of -31.07% of the last 4 quarters.

Miromatrix Medical Inc. (MIRO) Historical ROE (quarterly & annually)

How has MIRO ROE performed in the past?

The mean historical ROE of Miromatrix Medical Inc. over the last ten years is -29.52%. The current -119.21% ROE has changed 303.83% with respect to the historical average. Over the past ten years (40 quarters), MIRO's ROE was at its highest in in the December 2020 quarter at 2.13%. The ROE was at its lowest in in the September 2023 quarter at -41.52%.

Miromatrix Medical Inc. (MIRO) ROE by Quarter and Year

Discovering the peaks and valleys of Miromatrix Medical Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Miromatrix Medical Inc. (MIRO) Average ROE

How has MIRO ROE performed in the past?

The current ROE of Miromatrix Medical Inc. (MIRO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Miromatrix Medical Inc. (MIRO) ROE vs. Peers

How is MIRO’s ROE compared to its peers?

Miromatrix Medical Inc.’s ROE is greater than Anebulo Pharmaceuticals, Inc. (-122.97%), greater than PMV Pharmaceuticals, Inc. (-21.96%), less than ZIVO Bioscience, Inc. (673.84%), greater than Bionomics Limited (-150.24%), greater than Molecular Partners AG (-33.08%), greater than Mineralys Therapeutics, Inc. (-42.61%), greater than AN2 Therapeutics, Inc. (-54.72%), greater than Pharvaris N.V. (-36.89%), greater than PepGen Inc. (-62.74%), greater than NervGen Pharma Corp. (-267.77%), greater than Acrivon Therapeutics, Inc. Common Stock (-47.31%), greater than Protagenic Therapeutics, Inc. (-238.37%), greater than Inhibikase Therapeutics, Inc. (-194.17%), greater than Eliem Therapeutics, Inc. (-47.03%), greater than HCW Biologics Inc. (-385.90%),

Build a custom stock screener for Miromatrix Medical Inc. (MIRO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Miromatrix Medical Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Miromatrix Medical Inc. (MIRO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Miromatrix Medical Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.